United States · Series A startup

Who invested in Light Horse Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$62Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $62MJan 2025
Investors
3
See who backed them

The rounds

  1. Jan 2025
    Series A$62M

    Source recorded

Founders and team

From Light Horse Therapeutics's own website: 1 on the team.

  • David GaieroChief Financial Officer

Everyone who backed them

Versant VenturesVC firm1round
MubadalaPrivate equity1round
AbbVieCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Light Horse Therapeutics

Who invested in Light Horse Therapeutics?

Light Horse Therapeutics's investors include Versant Ventures, Mubadala and AbbVie.

How much has Light Horse Therapeutics raised?

Light Horse Therapeutics has raised $62M across 1 round since 2025.

When did Light Horse Therapeutics last raise?

Light Horse Therapeutics's most recent round was a Series A of $62M in Jan 2025.

What was Light Horse Therapeutics's biggest round?

Its most recent round, $62M in Jan 2025, is also its largest on record.

Who backed Light Horse Therapeutics first?

Light Horse Therapeutics's first round on record, in Jan 2025, was backed by Versant Ventures, Mubadala and AbbVie.

What stage is Light Horse Therapeutics at?

Light Horse Therapeutics's latest named round is a Series A, in Jan 2025.

Where is Light Horse Therapeutics based?

Light Horse Therapeutics is based in the United States.

Companies like Light Horse Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.